A detailed history of Southeast Asset Advisors Inc. transactions in Bio Techne Corp stock. As of the latest transaction made, Southeast Asset Advisors Inc. holds 29,786 shares of TECH stock, worth $2.13 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
29,786
Previous 27,867 6.89%
Holding current value
$2.13 Million
Previous $2.15 Million 2.51%
% of portfolio
0.25%
Previous 0.29%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$65.98 - $77.09 $126,615 - $147,935
1,919 Added 6.89%
29,786 $2.1 Million
Q4 2023

Feb 13, 2024

SELL
$52.83 - $78.22 $82,678 - $122,414
-1,565 Reduced 5.32%
27,867 $2.15 Million
Q3 2023

Nov 14, 2023

BUY
$67.52 - $89.42 $192,972 - $255,562
2,858 Added 10.75%
29,432 $2 Million
Q2 2023

Aug 10, 2023

SELL
$73.76 - $85.98 $884,751 - $1.03 Million
-11,995 Reduced 31.1%
26,574 $2.17 Million
Q1 2023

May 11, 2023

BUY
$71.62 - $86.62 $1,074 - $1,299
15 Added 0.04%
38,569 $2.86 Million
Q4 2022

Feb 09, 2023

BUY
$80.67 - $352.29 $2.61 Million - $11.4 Million
32,396 Added 526.08%
38,554 $3.2 Million
Q3 2022

Nov 04, 2022

BUY
$282.54 - $391.85 $541,629 - $751,176
1,917 Added 45.2%
6,158 $1.75 Million
Q2 2022

Aug 15, 2022

BUY
$322.67 - $449.65 $825,389 - $1.15 Million
2,558 Added 151.99%
4,241 $1.47 Million
Q1 2022

May 13, 2022

BUY
$353.85 - $487.79 $595,529 - $820,950
1,683 New
1,683 $729,000
Q3 2018

Nov 14, 2018

SELL
$147.44 - $204.11 $275,123 - $380,869
-1,866 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$144.9 - $165.58 $426,875 - $487,798
-2,946 Reduced 61.22%
1,866 $276,000
Q1 2018

May 15, 2018

SELL
$131.46 - $151.04 $538,854 - $619,112
-4,099 Reduced 46.0%
4,812 $727,000
Q4 2017

Feb 14, 2018

SELL
$121.17 - $134.75 $28,111 - $31,262
-232 Reduced 2.54%
8,911 $1.15 Million
Q3 2017

Nov 14, 2017

BUY
$113.59 - $123.78 $1.04 Million - $1.13 Million
9,143
9,143 $1.11 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.8B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Southeast Asset Advisors Inc. Portfolio

Follow Southeast Asset Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Southeast Asset Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Southeast Asset Advisors Inc. with notifications on news.